Injection Technique in Subacromial Impingement Syndrome
SAIS
Comparison of Clinical Results of Ultrasound-Guided Versus Blind Subacromial Corticosteroid Injections in Subacromial Impingement Syndrome
1 other identifier
observational
40
1 country
1
Brief Summary
Since pain is usually accompanied by a substantial effect on daily life that results in the extensive use of healthcare resources. In subacromial impingement syndrome, shoulder pain affects the quality of life negatively by affecting upper extremity functions and interrupting night sleep. It is very important to control the pain in order to reduce the loss to the labor force and prevent the pain from becoming chronic. Various physical treatment methods such as ultrasound, hot pack, transcutaneous electrical nerve stimulation, etc., and injections or medical agents are recommended. This study aimed to compare the effects of ultrasound (US)-guided in comparison to landmark guided subacromial corticosteroids injection on shoulder range of motion (ROM), pain, and functional status in patients with subacromial impingement syndrome (SAIS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 28, 2022
CompletedFirst Posted
Study publicly available on registry
March 4, 2022
CompletedMarch 4, 2022
February 1, 2022
Same day
February 28, 2022
February 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Visual analogue scale (VAS)
It is a scale scored from 0 to 10 to evaluate the severity of pain. Patients are asked to rate the pain they feel as '0' for no pain and '10' for the most severe pain they have encountered in their life
Change from baseline visual analogue scale score at 1 month
Secondary Outcomes (3)
Shoulder joint range of motion (ROM)
Change from baseline Shoulder joint range of motion at 1 month
Shoulder Pain and Disability Index (SPADI)
Change from baseline Shoulder Pain and Disability Index at 1 month
The Shortened Disabilities of the Arm, Shoulder and Hand Questionnaire (Quick DASH)
Change from baseline The Shortened Disabilities of the Arm, Shoulder and Hand Questionnaire at 1 month
Study Arms (2)
group 1
patients who received US-guided subacromial corticosteroid injections
group 2
patients who underwent blind subacromial corticosteroid injections
Interventions
Patients with SAIS whose application of corticosteroid in their injections were the same in terms of type and dose (1 ml betamethasone dipropionate + betamethasone sodium phosphate).
Eligibility Criteria
Patients with the diagnosis of Subacromial impingement syndrome who underwent subacromial corticosteroid injections in our interventional physiatry clinic between September 2017 and February 2018 were included in this study.
You may qualify if:
- Shoulder posterolateral pain that increased with shoulder abduction,
- Restriction of the shoulder passive and active range of motion (ROM),
- Patients with positive Neer and Hawkins impingement test,
- Patients with SAIS whose diagnosis was confirmed by magnetic resonance imaging (MRI), and
- Patients with SAIS whose application of corticosteroid in their injections were the same in terms of type and dose (1 ml betamethasone dipropionate + betamethasone sodium phosphate).
You may not qualify if:
- Patients who received corticosteroid, local anesthetic, hyaluronic acid, and platelet-rich plasma injections in the shoulder in the last one year,
- patients who had previous history of surgery or fracture in their thorax, neck, upper extremity or shoulder joint,
- patients with a rheumatological, cognitive or psychiatric, central or peripheral neurological disease (stroke, spinal cord injury, brachial plexus injury, etc.),
- patients whose MRI presented a partial or complete rotator cuff tear, calcific tendinitis or labral tear.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Physical Medicine and Rehabilitation Training and Research Hospital
Istanbul, 34186, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kadriye Ones, Prof
Istanbul Physical Medicine Rehabilitation Training & Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2022
First Posted
March 4, 2022
Study Start
June 1, 2018
Primary Completion
June 1, 2018
Study Completion
September 1, 2018
Last Updated
March 4, 2022
Record last verified: 2022-02